Mycobacterium florentinum pulmonary disease: a case report and review of the literature
As with MAC pulmonary disease, combination antimicrobial therapy including ALIS was successful in a patient affected by a difficult-to-treat pulmonary infection caused by Mycobacterium florentinum, a rare NTM pathogen. Combination antibiotic treatment including ALIS may also be considered for other difficult-to-treat, non-MAC NTM- pulmonary diseases. During treatment, patients should be monitored for the emergence of Aspergillus co-infection.
Authors
- Fabian Leo (ORCID: https://orcid.org/0000-0003-3053-1737)
- Silke Polsfuß
- Anne-Sophie Przewosnik
- Christoph Lange
- Christian Grohé (ORCID: https://orcid.org/0000-0003-2724-7647)
Institutions
- Helios Klinikum Emil von Behring (DE)
- German Center for Infection Research (DE)
- Research Center Borstel - Leibniz Lung Center (DE)
- Texas Children's Hospital (US)
- Evangelische Lungenklinik Berlin (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1186/s12879-025-12321-3
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00